These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12513683)

  • 21. ECVAM's approach to intellectual property rights in the validation of alternative methods.
    Linge JP; Hartung T
    Altern Lab Anim; 2007 Aug; 35(4):441-6. PubMed ID: 17850189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation successes: chemicals.
    Spielmann H; Liebsch M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():33-40. PubMed ID: 12513649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECVAM's in-house prevalidation/validation studies in the areas of haematotoxicity, reproductive toxicity, metabolism-mediated toxicity and epithelial barrier function.
    Prieto P
    Sci Total Environ; 2000 Mar; 247(2-3):349-54. PubMed ID: 10803561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal tests inescapable.
    Nature; 2008 May; 453(7195):563-4. PubMed ID: 18509386
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models.
    Bremer S; Pellizzer C; Adler S; Paparella M; de Lange J
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():107-9. PubMed ID: 12513659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECVAM-ICCVAM: prospects for future collaboration.
    Schechtman LM; Stokes WS
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():227-36. PubMed ID: 12513682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contributions of the European cosmetics industry to the development of alternatives to animal testing: dialogue with ECVAM and future challenges.
    de Silva O;
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():189-93. PubMed ID: 12513672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
    Pfaller W; Balls M; Clothier R; Coecke S; Dierickx P; Ekwall B; Hanley BA; Hartung T; Prieto P; Ryan MP; Schmuck G; Sladowski D; Vericat JA; Wendel A; Wolf A; Zimmer J
    Altern Lab Anim; 2001; 29(4):393-426. PubMed ID: 11506637
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicity testing: creating a revolution based on new technologies.
    Bhogal N; Grindon C; Combes R; Balls M
    Trends Biotechnol; 2005 Jun; 23(6):299-307. PubMed ID: 15922082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the second FRAME Toxicity Committee (1991).
    Combes R; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizu G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2002; 30(4):365-406. PubMed ID: 12234245
    [No Abstract]   [Full Text] [Related]  

  • 33. The seventh amendment to the cosmetics directive: what does DG enterprise want from ECVAM?
    Schumann R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():213-4. PubMed ID: 12513678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status and future progress of reproductive/developmental toxicity test].
    Akita M
    Yakugaku Zasshi; 2008 May; 128(5):765-72. PubMed ID: 18451625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three Rs Approaches in Marine Biotoxin Testing. The Report and Recommendations of a joint ECVAM/DG SANCO Workshop (ECVAM Workshop 54).
    Hess P; Grune B; Anderson DB; Aune T; Botana LM; Caricato P; van Egmond HP; Halder M; Hall S; Lawrence JF; Moffat C; Poletti R; Richmond J; Rossini GP; Seamer C; Vilageliu JS;
    Altern Lab Anim; 2006 May; 34(2):193-224. PubMed ID: 16704292
    [No Abstract]   [Full Text] [Related]  

  • 37. ECVAM: desperately needed or superfluous? An animal welfare perspective.
    Kolar R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():169-74. PubMed ID: 12513669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of three Rs alternatives in regulatory testing: possibilities and obstacles--the view of the validator.
    Halder M; Balls M
    Dev Biol (Basel); 2002; 111():199-206. PubMed ID: 12678242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
    Stokes WS; Schechtman LM; Hill RN
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
    Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.